Fidelity Investments’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,600
| Closed | -$3.79K | – | 5421 |
|
|
2025
Q1 | $3.79K | Hold |
4,600
| – | – | ﹤0.01% | 4773 |
|
|
2024
Q4 | $4.37K | Buy |
4,600
+800
| +21% | +$755 | ﹤0.01% | 4693 |
|
|
2024
Q3 | $3.8K | Buy |
3,800
+600
| +19% | +$664 | ﹤0.01% | 4677 |
|
|
2024
Q2 | $3.97K | Hold |
3,200
| – | – | ﹤0.01% | 4613 |
|
|
2024
Q1 | $4.16K | Sell |
3,200
-362,000
| -99% | -$413K | ﹤0.01% | 4562 |
|
|
2023
Q4 | $457K | Buy |
365,200
+360,508
| +7,683% | +$399K | ﹤0.01% | 2708 |
|
|
2023
Q3 | $6.1K | Sell |
4,692
-1,273
| -21% | -$2.06K | ﹤0.01% | 4285 |
|
|
2023
Q2 | $10.3K | Buy |
5,965
+1,788
| +43% | +$2.84K | ﹤0.01% | 4132 |
|
|
2023
Q1 | $6.1K | Sell |
4,177
-617,565
| -99% | -$1.18M | ﹤0.01% | 4323 |
|
|
2022
Q4 | $1.01M | Sell |
621,742
-882,492
| -59% | -$2.03M | ﹤0.01% | 2539 |
|
|
2022
Q3 | $5.04M | Buy |
1,504,234
+5,326
| +0.4% | +$24K | ﹤0.01% | 2174 |
|
|
2022
Q2 | $5.46M | Sell |
1,498,908
-487,619
| -25% | -$2.21M | ﹤0.01% | 2212 |
|
|
2022
Q1 | $14.4M | Buy |
1,986,527
+224,733
| +13% | +$1.92M | ﹤0.01% | 1952 |
|
|
2021
Q4 | $23.9M | Buy |
1,761,794
+134,506
| +8% | +$2.1M | ﹤0.01% | 1742 |
|
|
2021
Q3 | $34.1M | Sell |
1,627,288
-163,707
| -9% | -$3.52M | ﹤0.01% | 1595 |
|
|
2021
Q2 | $42.9M | Sell |
1,790,995
-178,708
| -9% | -$4.52M | ﹤0.01% | 1520 |
|
|
2021
Q1 | $57.3M | Sell |
1,969,703
-598,199
| -23% | -$17.5M | ﹤0.01% | 1332 |
|
|
2020
Q4 | $73M | Buy |
+2,567,902
| New | +$80.6M | 0.01% | 1169 |
|
Fidelity Investments's KRON Position: Q2 2025 in Review
Fidelity Investments sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 4,600 shares — an estimated $3.79K sold.
Fidelity Investments first reported a position in KRON in Q4 2020 and held it in 18 quarters. The position peaked at $73M in Q4 2020. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.
- Fidelity Investments reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
- Fidelity Investments sold 4,600 Kronos Bio shares in Q2 2025, an estimated $3.79K.
- Fidelity Investments first reported a position in Kronos Bio in Q4 2020 and held it in 18 quarters.
- Fidelity Investments's Kronos Bio position peaked at $73M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.
Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.